Epigral is accelerating its capacity expansion programme, with its CPVC and ECH projects entering their final stages and trial runs already underway ...

Neogen, however, continued to face cost pressures arising from the Dahej plant rebuild, tolling arrangements, capital expenditure at NIL and elevated input costs ...

Privi Speciality Chemicals has delivered a strong performance in the second quarter of FY27, posting a 24.61% year-on-year jump in profit after tax (PAT) to Rs 117.03 crore, backed by robust revenue ...

The global agricultural leader registered group sales of $17.3 billion for the first nine months of the year ...

Advantaged investments, technology, and $16.9 billion in structural cost savings since 2019 are expanding our earnings power ...

However, statutory Profit After Tax (PATMI) fell 24% YoY to Rs. 421 crore due to an 18% spike in net finance costs ...

In H1 27, the company has achieved a turnover of Rs 13,488 crore higher by 19%, EBIDTA of Rs 1173 crore ...

ADAMA has appointed Dr. Zhigang Hao as President and Chief Executive Officer of ADAMA, effective November 1, 2026. Zhigang ...

AVEVA is spotlighting the entire asset lifecycle—spanning design, build, operation, maintenance, and optimization ...

Contract follows successful Process Development and scale-up of a new product, marking a key commercial milestone for Hikal’s ...

Adjusted EBITDA also declined to $191.4 million from $222.4 million in the third quarter of 2025, reflecting continued ...

Operating profit for the quarter reached $198 million, accompanied by an adjusted EBIT of $367 million and operating EBITDA of $548 million. Management highlighted strong cash generation during the ...